Receive Windhover's unique market insight fast with our free alert
service 'Windhover's Update', including the latest abstracts
and summaries from:
• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight
Sign up
now
|
|
|
|
In 90 minutes or less, Elsevier Business Intelligence Webinars provide need-to-know intelligence on compliance and business issues you face every day. You’ll hear from, and be able to ask questions of the leading experts in regulated industry. |
 |
Listen by yourself, or train your entire team for one low price—all you need is a phone and Internet connection. CD recordings and transcripts are also available, so you and your colleagues can review what you what, whenever you want.
Here’s what’s coming up; to learn more or to order, click below on the program of your choice, or call Customer Care at 1-800-332-2181 or 1-908-547-2159.
|
| Upcoming Webinars |
| Medical Device Approvals in the European Union: Significant Changes Now in Effect |
| Tuesday, September 14, 2010 - 11:00AM EDT/8:00AM PDT - 90 min. |
|
|
| Clinical Trial Agreements: Avoiding Problem Indemnification Clauses |
| Tuesday, September 21, 2010 - 1:00PM EDT/10:00AM PDT - 90 min. |
|
|
| FDA GMP Enforcement: Avoid the Public Spotlight |
| Thursday, September 23, 2010 - 1:00PM EDT/10:00AM PDT - 90 min. |
|
|
Webinar Cancellation Policy:
No refunds or credits will be given one week prior to the scheduled
webinar, or after the webinar presentation materials
and access instructions have been sent to participants. In lieu
of cancellation, you may substitute another delegate from your
company as a replacement.
|
| Previous Elsevier Business Intelligence Webinars |
Missed the live presentation? You don't need to miss out. The same specific, actionable insight is available on CD and transcript. Includes the audio and slide deck integrated into one file, plus the full question and answer session--so it's just like you were there. Also includes a digital and printed transcript, so you can revisit the knowledge you want whenever you want.
|
|
August 31,
2010 -
Former FDA Investigator shows how to Respond to FDA Form 483s for Device Makers |
|
|
August 24,
2010 -
Drug Development Strategies: Planning a Successful Clinical Development Program |
|
|
August 19,
2010 -
The ABCs of GCP: What Everyone on Your Team Should Know About Clinical Compliance in the Real World |
|
|
August 10,
2010 -
Off-Label, Online: Know What the FDA expects before Internet Promotion Guidance is Released |
|
|
August 4,
2010 -
Medical Device Complaint Handling: What the New FDA Wants to See Today (and How to Show Them) |
|
|
July 29,
2010 -
What the New 510(k) Will Mean for You |
|
|
July 27,
2010 -
Conducting Internal Investigations at Medical Device Companies |
|
|
July 22,
2010 -
Clinical Trial Agreements for Sponsors: Don't just Trust Your Template |
|
|
July 8,
2010 -
Approval Strategies: Leveraging the Unapproved Drug Initiative |
|
|
June 23,
2010 -
Dietary Supplement Claims Compliance: Is the FDA Redefining the Supplement Standard |
|
|
June 16,
2010 -
CAPA for Medical Devices: The Latest Advice and Insight for Reaching Complete Compliance |
|
|
June 10,
2010 -
Follow-On Biologics: Strategies to Benefit from Regulatory Changes Coming in the Next 12 Months |
|
|
June 8,
2010 -
The Post-Reform World of Drug and Device Coverage and Reimbursement: New Evidence and New Institutions |
|
|
June 3,
2010 -
REMS: Structuring a Strategy that Reduces Your Regulatory and Liability Exposure |
|
|
June 1,
2010 -
Michael Loucks, Former DoJ Prosecutor, Shares What You Must Do to Ensure Compliance |
|
|
May 27,
2010 -
510(k) is Changing: What You Must Know to Obtain Clearance |
|
|
May 25,
2010 -
The Future of Medicare Part D Post Health Care Reform |
|
|
May 18,
2010 -
Off-Label Promotion: Dos & Don’ts for Monitoring and Maintaining Promotional Compliance |
|
|
May 11,
2010 -
Life Science Mergers & Acquisitions: How Health Care Reform will Change your Partnering Strategy |
|
|
February 11,
2010 -
Capitalizing on New FDA Guidance: The Promise and Perils of Disseminating Scientific Literature About Off-Label Use of Medical Devices |
|
|
January 21,
2010 -
FDA's Enforcement Initiative: What should you do differently? |
|
|
January 20,
2010 -
The Road to FDA Approval: Advisory Committee Survival Strategies |
|
|
For more information or to register for these insightful
and interactive webinars, please contact:
Customer Care
Email: custcare@elsevier.com
Toll Free: (800) 332-2181
Tel: (908) 547-2159
Fax: (908) 547-2165
Or register online via the links above.
|
|
 |
|
 |
|
|
| |
 |
Novartis Follows Its Own Business Development Model into Molecular Diagnostics
Novartis is mirroring its approach to pharma R&D and leveraging the byproducts of its biomarker work there to build a commercial molecular diagnostics franchise. The head of the unit talks about its structure, strategy and programs. . . [MORE] (IN VIVO)
Bioactive Technologies For Bone Replacement
Expanded indications for bone morphogenetic proteins and new alternatives to those first-generation bone growth factors have the potential to grow the $2 billion market for bone replacement materials. . . [MORE] (Start-Up)
Laser Cataract Surgery Comes into Focus at ASCRS
The mood was primarily upbeat at April's annual meeting of the American Society of Cataract and Refractive Surgery. Most in attendance expected a modest rebound in procedure volumes for 2010. . . [MORE] (Medtech Insight)
FDA, Drug Development and Health Care Reform: A Panel Discussion
Current and former FDA officials and a former Big Pharma head of R&D discuss FDA and the relationship between a regulator and the industry it regulates when it comes to drug development. . . [MORE] (The RPM Report)
Read
more from the latest:
IN VIVO,
Start-Up,
The RPM Report,
Medtech Insight, "The Pink Sheet",
"The Pink Sheet" DAILY,
"The Rose Sheet",
"The Tan Sheet",
PharmAsia News,
Pharmaceutical Approvals Monthly, and
"The Gray Sheet".
|
|
|
|
| |
|
|
|
|
|
